EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Efficacy of a Conversational AI Agent for Psychiatric Symptoms and Digital Therapeutic Alliance

Anat Shoshani, Bar Gurfinkel, Ariel Kor, Yael Ben-Haim, Or Kanarek, Romi Segev, Or Shafir, Romi Arbel

JAMA Network Open · 14.04.2026 · 9 (4) · e266713

DOI: 10.1001/jamanetworkopen.2026.6713 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, online erschienen am 14.04.2026. Verfasst von Anat Shoshani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Baruch Ivcher School of Psychology, Reichman University, Herzliya, Israel. Hauptthemen laut MEDLINE: Therapeutic Alliance, Artificial Intelligence, Mental Disorders. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Accessible, scalable interventions for psychiatric symptoms are needed to address global mental health care gaps. Conversational artificial intelligence (AI) may extend access by providing personalized support, yet rigorous evidence of efficacy and therapeutic mechanisms remains scarce.

Objectives

To evaluate the efficacy of a conversational AI–based mental health platform for psychiatric symptoms, and to assess how perceived therapeutic alliance contributes to user engagement and psychological outcomes. Design, Setting, and Participants This 3-arm randomized clinical trial was conducted in Israel from April 1 to October 27, 2025, including the 12-week intervention and 3-month follow-up period. Participants were university students who reported psychological distress.

Interventions

Participants were randomly assigned 1:1:1 to a 12-week AI-based conversational platform, face-to-face group therapy, or waiting list control. Main Outcomes and Measures The primary outcomes were anxiety (Generalized Anxiety Disorder-7), depression (Patient Health Questionnaire-9), posttraumatic stress disorder (PTSD; PTSD Checklist for DSM-5 ), well-being (World Health Organization-5 Well-Being Index), and life satisfaction (Brief Multidimensional Students’ Life Satisfaction Scale) measures at the end of the 12-week intervention. Analyses followed the intention-to-treat principle.

Results

In total, 995 participants (mean [SD] age, 23.1 [2.4] years; 504 [50.7%] female) were included in analyses, with 336 randomized to the AI intervention, 331 to group therapy, and 328 to waiting list control. After the intervention, participants in the AI group showed greater anxiety reduction than those in group therapy (mean difference [MD], −2.17 [95% CI, −2.67 to −1.67]) or control (MD, −2.15 [95% CI, −2.65 to −1.65]) and greater depression reduction than control (MD, −1.99 [95% CI, −2.63 to −1.35]). PTSD symptoms did not differ among groups. The AI group also showed greater improvements in well-being than group therapy (MD, 5.72 [95% CI, 2.71 to 8.73]) and control (MD, 9.16 [95% CI, 6.14 to 12.18]). Structural equation modeling indicated that perceived therapeutic alliance was associated with engagement (β = 0.31 [95% CI, 0.16 to 0.43]; P < .001) and symptom improvement (β = –0.58 [95% CI, –0.69 to –0.46]; P < .001). Conclusions and Relevance In this randomized clinical trial of university students with psychological distress, the use of a conversational AI agent was associated with improvements in anxiety, depression, well-being, and life satisfaction, and its perceived therapeutic alliance was associated with engagement and psychological improvement. These findings suggest that conversational AI may serve as a scalable resource within mental health frameworks. Trial Registration ISRCTN Registry Identifier: ISRCTN61075527

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Therapeutic AllianceArtificial IntelligenceMental DisordersHumansFemaleMaleAdultYoung AdultIsraelStress Disorders, Post-TraumaticTreatment OutcomeMental Health TeletherapyDepression

Autor:innen und Institutionen

  • Baruch Ivcher School of Psychology, Reichman University, Herzliya, Israel.
  • Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • School of Medicine, Yale University, New Haven, Connecticut.

Zitieren

APA

Shoshani, A., Gurfinkel, B., Kor, A., Ben-Haim, Y., Kanarek, O., Segev, R., Shafir, O., & Arbel, R. (2026). Efficacy of a Conversational AI Agent for Psychiatric Symptoms and Digital Therapeutic Alliance. JAMA Network Open, 9(4), e266713. https://doi.org/10.1001/jamanetworkopen.2026.6713

Vancouver

Shoshani A, Gurfinkel B, Kor A, Ben-Haim Y, Kanarek O, Segev R, et al. Efficacy of a Conversational AI Agent for Psychiatric Symptoms and Digital Therapeutic Alliance. JAMA Network Open. 2026;9(4):e266713. doi:10.1001/jamanetworkopen.2026.6713

BibTeX
@article{Shoshani2026,
  author = {Shoshani, Anat and Gurfinkel, Bar and Kor, Ariel and Ben-Haim, Yael and Kanarek, Or and Segev, Romi and Shafir, Or and Arbel, Romi},
  title = {Efficacy of a Conversational AI Agent for Psychiatric Symptoms and Digital Therapeutic Alliance},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {4},
  pages = {e266713},
  doi = {10.1001/jamanetworkopen.2026.6713}
}
Kostenlos starten →